- Home
- NKX vs CRMD Comparison
NKX vs CRMD Comparison
Compare NKX & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKX
- CRMD
- Stock Information
- Founded
- NKX 2002
- CRMD 2006
- Country
- NKX United States
- CRMD United States
- Employees
- NKX N/A
- CRMD N/A
- Industry
- NKX Finance/Investors Services
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- NKX Finance
- CRMD Health Care
- Exchange
- NKX Nasdaq
- CRMD Nasdaq
- Market Cap
- NKX 599.7M
- CRMD 753.6M
- IPO Year
- NKX N/A
- CRMD 2010
- Fundamental
- Price
- NKX $12.92
- CRMD $10.57
- Analyst Decision
- NKX
- CRMD Strong Buy
- Analyst Count
- NKX 0
- CRMD 6
- Target Price
- NKX N/A
- CRMD $15.67
- AVG Volume (30 Days)
- NKX 109.3K
- CRMD 1.5M
- Earning Date
- NKX 01-01-0001
- CRMD 03-11-2025
- Dividend Yield
- NKX 4.37%
- CRMD N/A
- EPS Growth
- NKX N/A
- CRMD N/A
- EPS
- NKX N/A
- CRMD N/A
- Revenue
- NKX N/A
- CRMD $12,262,234.00
- Revenue This Year
- NKX N/A
- CRMD N/A
- Revenue Next Year
- NKX N/A
- CRMD $246.41
- P/E Ratio
- NKX N/A
- CRMD N/A
- Revenue Growth
- NKX N/A
- CRMD 41184.20
- 52 Week Low
- NKX $9.78
- CRMD $2.89
- 52 Week High
- NKX $12.00
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- NKX 56.81
- CRMD 40.80
- Support Level
- NKX $12.62
- CRMD $11.90
- Resistance Level
- NKX $12.67
- CRMD $12.67
- Average True Range (ATR)
- NKX 0.12
- CRMD 0.73
- MACD
- NKX 0.03
- CRMD -0.27
- Stochastic Oscillator
- NKX 77.78
- CRMD 2.12
About NKX Nuveen California AMT-Free Quality Municipal Income Fund
Nuveen California AMT-Free Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objectives are to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.